Surrogate markers for time-varying treatments and outcomes

Clin Trials. 2015 Aug;12(4):309-16. doi: 10.1177/1740774515583500. Epub 2015 May 6.

Abstract

Background: A surrogate marker is a variable commonly used in clinical trials to guide treatment decisions when the outcome of ultimate interest is not available. A good surrogate marker is one where the treatment effect on the surrogate is a strong predictor of the effect of treatment on the outcome. We review the situation when there is one treatment delivered at baseline, one surrogate measured at one later time point, and one ultimate outcome of interest and discuss new issues arising when variables are time-varying.

Methods: Most of the literature on surrogate markers has only considered simple settings with one treatment, one surrogate, and one outcome of interest at a fixed time point. However, more complicated time-varying settings are common in practice. In this article, we describe the unique challenges in two settings, time-varying treatments and time-varying surrogates, while relating the ideas back to the causal-effects and causal-association paradigms.

Conclusion: In addition to discussing and extending popular notions of surrogacy to time-varying settings, we give examples illustrating that one can be misled by not taking into account time-varying information about the surrogate or treatment. We hope this article has provided some motivation for future work on estimation and inference in such settings.

Keywords: Causal inference; observational studies; randomization; surrogacy; time-varying.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Biomarkers*
  • Clinical Trials as Topic
  • Humans
  • Mathematical Concepts
  • Outcome Assessment, Health Care*
  • Regression Analysis
  • Therapeutics*
  • Time Factors

Substances

  • Biomarkers